Cargando…

CD73 Severed as a Potential Prognostic Marker and Promote Lung Cancer Cells Migration via Enhancing EMT Progression

To investigate the expression levels and prognostic value of CD73 in lung cancer. And moreover, to identify the effect and potential mechanism of CD73 on lung cancer cells proliferation and migration. CD73 expression levels in lung cancer were analyzed base on GEPIA2 and GEO database. GEPIA2 and Kap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Zhao-wei, Liu, Chong, Yang, Lan, Chen, Hao-chuan, Yang, Long-fei, Zhang, Hui-zhong, Dong, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635862/ https://www.ncbi.nlm.nih.gov/pubmed/34868205 http://dx.doi.org/10.3389/fgene.2021.728200

Ejemplares similares

A role for EMT in CD73 regulation in breast cancer
por: Hasmim, Meriem, et al.
Publicado: (2022)

CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer
por: Petruk, Nataliia, et al.
Publicado: (2021)

Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-mesenchymal transition (EMT) related molecules in Hepatocellular Carcinoma (HCC)
por: Bao, Yong xing, et al.
Publicado: (2013)

CD73 Rather Than CD39 Is Mainly Involved in Controlling Purinergic Signaling in Calcified Aortic Valve Disease
por: Kudryavtsev, Igor, et al.
Publicado: (2019)

Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer
por: Li, Danfeng, et al.
Publicado: (2021)

The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014)

CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity
por: Gao, Zhao-wei, et al.
Publicado: (2017)

Evaluation of CD44+/CD24- and Aldehyde Dehydrogenase Enzyme Markers in Cancer Stem Cells as Prognostic Indicators for Triple-Negative Breast Cancer
por: Escudero Mendez, Lisbeth, et al.
Publicado: (2022)

Identification of EMT-Related Gene Signatures to Predict the Prognosis of Patients With Endometrial Cancer
por: Cai, Luya, et al.
Publicado: (2020)

Investigation of Prognostic Markers of Lung Adenocarcinoma Based on Tumor Metabolism-Related Genes
por: Zhang, Chong, et al.
Publicado: (2021)

CD73 promotes tumor metastasis by modulating RICS/RhoA signaling and EMT in gastric cancer
por: Xu, Zhijun, et al.
Publicado: (2020)

Serum Golgi Protein 73 (GP73) is a Diagnostic and Prognostic Marker of Chronic HBV Liver Disease
por: Xu, Zhengju, et al.
Publicado: (2015)

CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer
por: Chen, Qiangda, et al.
Publicado: (2020)

CDH6 as a prognostic indicator and marker for chemotherapy in gliomas
por: Meng, Ming, et al.
Publicado: (2022)

The distinct role of CD73 in the progression of pancreatic cancer
por: Zhou, Liangjing, et al.
Publicado: (2019)

The Effects of CD73 on Gastrointestinal Cancer Progression and Treatment
por: Sun, Pengcheng, et al.
Publicado: (2022)

CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

Identifying the EMT-related signature to stratify prognosis and evaluate the tumor microenvironment in lung adenocarcinoma
por: Li, Feng, et al.
Publicado: (2022)

BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity
por: Katheeja, Muhseena N., et al.
Publicado: (2023)

Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast
por: Feng, Xiaolong, et al.
Publicado: (2017)

CD73 promotes cervical cancer growth via EGFR/AKT1 pathway
por: Liu, Chong, et al.
Publicado: (2022)

BTC as a Novel Biomarker Contributing to EMT via the PI3K-AKT Pathway in OSCC
por: Shen, Ting, et al.
Publicado: (2022)

Refined expression quantitative trait locus analysis on adenocarcinoma at the gastroesophageal junction reveals susceptibility and prognostic markers
por: Zhong, Ce, et al.
Publicado: (2023)

TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT
por: Huang, Zhengnan, et al.
Publicado: (2021)

Delta-catenin attenuates medulloblastoma cell invasion by targeting EMT pathway
por: Hu, Yuanjun, et al.
Publicado: (2022)

Microfibrillar-associated protein 2 is a prognostic marker that correlates with the immune microenvironment in glioma
por: Xu, Wanzhen, et al.
Publicado: (2022)

CD73 is associated with poor prognosis in HNSCC
por: Ren, Zhen-Hu, et al.
Publicado: (2016)

Identification of LncRNA Prognostic Markers for Ovarian Cancer by Integration of Co-expression and CeRNA Network
por: Liang, Huisheng, et al.
Publicado: (2021)

A novel ten-gene prognostic signature for cervical cancer based on CD79B-related immunomodulators
por: Pu, Dan, et al.
Publicado: (2022)

Elevated Serum FGG Levels Prognosticate and Promote the Disease Progression in Prostate Cancer
por: Peng, H. H., et al.
Publicado: (2021)

Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer
por: Dai, Weiyu, et al.
Publicado: (2021)

TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis via EMT Signaling Pathway
por: Shou, Yi, et al.
Publicado: (2022)

KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer
por: Jia, Shuqin, et al.
Publicado: (2017)

Construction and Analysis of a ceRNA Network Reveals Potential Prognostic Markers in Colorectal Cancer
por: Guo, Li, et al.
Publicado: (2020)

Immune-Related Genes Are Prognostic Markers for Prostate Cancer Recurrence
por: Fu, Min, et al.
Publicado: (2021)

PDCD10 promotes proliferation, migration, and invasion of osteosarcoma by inhibiting apoptosis and activating EMT pathway
por: Xu, Ke, et al.
Publicado: (2022)

The Trp73 Mutant Mice: A Ciliopathy Model That Uncouples Ciliogenesis From Planar Cell Polarity
por: Marques, Margarita M., et al.
Publicado: (2019)

A nine–consensus–prognostic –gene–based prognostic signature, recognizing the dichotomized subgroups of gastric cancer patients with different clinical outcomes and therapeutic strategies
por: Ji, Dan, et al.
Publicado: (2022)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

Identification and vitro verification of the potential drug targets of active ingredients of Chonglou in the treatment of lung adenocarcinoma based on EMT-related genes
por: Zhao, Fulai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qlh1aum761enpsfq2hk37gvvfi